<DOC>
	<DOCNO>NCT01577472</DOCNO>
	<brief_summary>The aim study ass oocyte yield infertile woman suspect known poor ovarian reserve ( POR ) undergo GnRH antagonist protocol IVF Merional® start either low ( 150 IU ) high dose ( 450 IU ) add 100mg CC ( Serophene® ) early follicular phase stimulation ( day 3 7 ) . To date RCT conduct compare reproductive outcome patient POR define ESHRE Bologna criterion control ovarian hyperstimulation HMG GnRH antagonist protocol use low dos versus high dos HMG add CC versus placebo . We hypothesize add 100 mg CC day 3-7 HMG antagonist protocol lead additional increment endogenous GT thus increase oocyte yield controlled ovarian stimulation due high endogenous gonadotropin secretion .</brief_summary>
	<brief_title>Efficacy Study Comparing Effect Clomiphencitrate Antagonist Protocol</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Female</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<criteria>Age : &gt; 18 year &lt; 43 year BMI : ≥ 18 ≤ 32 kg/m2 Poor responder define ESHRE work group Age &lt; 18 und &gt; 43 year Pregnancy Breast feed Uterine condition interfere endometrial proliferation embryo implantation ( submucous fibroid polyp ) Women diagnose PCOS accord Rotterdam criterion Hyperprolactinaemia untreated Both ovary accessible transvaginally oocyte pick Ovarian cyst unclear dignity Evidence hydrosalpinx ultrasound Clinically significant severe systemic disease incompatible pregnancy Known suspect hypersensitivity active substance ( gonadotrophin , ganirelix , progesterone , clomiphencitrate ) Untreated thyroid adrenal disorder Bleeding disorder Cancer Severe renal hepatic dysfunction Necessity take medication could influence ovarian stimulation History OHSS prior IVF cycle</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>female infertility</keyword>
	<keyword>poor ovarian response</keyword>
	<keyword>control ovarian hyperstimulation</keyword>
	<keyword>IVF</keyword>
	<keyword>Antagonist protocol</keyword>
</DOC>